NCCM
AVEO

Nine Chapters Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Nine Chapters Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,500
Closed -$94K – 1224
2015
Q1 		$94K Buy
+6,500
New +$71K 0.01% 901
2014
Q4 		– Sell
-8,120
Closed -$90K – 1270
2014
Q3 		$90K Buy
8,120
+2,690
+50% +$34.2K 0.01% 934
2014
Q2 		$99K Buy
5,430
+3,430
+172% +$44.6K 0.01% 877
2014
Q1 		$30K Buy
2,000
+750
+60% +$13.5K ﹤0.01% 786
2013
Q4 		$23K Sell
1,250
-150
-11% -$3K ﹤0.01% 769
2013
Q3 		$29K Buy
+1,400
New +$32.1K ﹤0.01% 724

Other funds holding AVEO

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DVC
Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
GX
Greylock XI Cambridge, Massachusetts $7.71M AUM 28.23% 1-Year Est. Return

Nine Chapters Capital Management's AVEO Position: Q2 2015 in Review

Nine Chapters Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2015, closing a stake of 6,500 shares — an estimated $94K sold.

Nine Chapters Capital Management first reported a position in AVEO in Q3 2013 and held it in 6 quarters. The position peaked at $99K in Q2 2014. 54 funds tracked by Wall St. Rank hold AVEO as of Q2 2015.

  • Nine Chapters Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 6,500 AVEO Pharmaceuticals, Inc. shares in Q2 2015, an estimated $94K.
  • Nine Chapters Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
  • Nine Chapters Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $99K in Q2 2014.
  • 54 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2015.

Based on Nine Chapters Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.